Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma. (Record no. 14436599)

MARC details
000 -LEADER
fixed length control field 01433 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250514165011.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200402s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0030-2414
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1159/000074641
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Raderer, Markus
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20040227
245 00 - TITLE STATEMENT
Title Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Oncology
Date of publication, distribution, etc. 2003
300 ## - PHYSICAL DESCRIPTION
Extent 306-10 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Murine-Derived
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antigens, CD20
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Epitopes, B-Lymphocyte
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunotherapy
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphoma, B-Cell, Marginal Zone
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Retrospective Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Rituximab
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jäger, Gerald
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Brugger, Stefan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Püspök, Andreas
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fiebiger, Wolfgang
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Drach, Johannes
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wotherspoon, Andrew
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chott, Andreas
773 0# - HOST ITEM ENTRY
Title Oncology
Related parts vol. 65
-- no. 4
-- p. 306-10
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1159/000074641">https://doi.org/10.1159/000074641</a>
Public note Available from publisher's website

No items available.